TOP 10 COMPANIES IN NEXT GENERATION SEQUENCING SERVICES MARKET
|
|
The global Next Generation Sequencing Services Market is poised for remarkable growth, projecting a robust Compound Annual
Growth Rate (CAGR) of 19.9% from 2023 to 2030, with an estimated market value
of $20.39 billion by the end of the forecast period.
Driving
Forces: The market's upward trajectory is fueled by
several key factors, including the decreasing costs associated with sequencing
procedures, the approval of novel targeted therapies, a surge in cancer
prevalence, strategic partnerships between NGS service providers and
pharmaceutical companies, the substantial investment in sequencing
infrastructure, and ongoing technological advancements in NGS.
Challenges: Despite these promising trends, the market faces challenges such as
the existence of alternative technologies, a shortage of skilled professionals
for sample preparation and analysis, and limited actionable mutations for
precision medicine.
Growth
Opportunities: Nevertheless, the expanding applications of
NGS in cancer and agri-genomics research, coupled with advances in sequencing
data analytics, present substantial growth opportunities for the market.
Top 10
Companies Driving Innovation: Here are
the top 10 companies at the forefront of the Next Generation Sequencing
Services Market: https://meticulousblog.org/top-10-companies-in-next-generation-sequencing-services-market/
- Illumina, Inc.
(U.S.)
- Founded in 1998,
Illumina offers sequencing and array-based solutions globally.
- Provides NGS
services through Core Illumina segment, including whole-genome
sequencing and noninvasive prenatal testing.
- Operates in North
America, Europe, Latin America, Asia-Pacific, and the Middle East &
Africa.
- Eurofins
Scientific S.E. (Luxembourg)
- Established in 1987,
Eurofins provides analytical testing services across industries.
- Operates in the NGS
Services market through BioPharmaceutical Services and Clinical
Diagnostics business area.
- Geographic presence
in over 60 countries.
- Invitae
Corporation (U.S.)
- Founded in 2010,
Invitae offers genetic testing services across various clinical areas.
- Key presence in the
U.S., the U.K., Canada, Germany, India, Australia, Japan, the Netherlands,
and Brazil.
- Foundation
Medicine, Inc. (U.S.)
- Founded in 2010, a
subsidiary of F. Hoffmann-La Roche AG (Switzerland).
- Specializes in
assays for next-generation sequencing, genomic profiling, and
immunohistochemistry.
- Presence in the
U.S., Brazil, Romania, and Germany.
- Beijing Genomics
Institute (China)
- Established in 1999,
BGI provides proteomics and genomics sequencing services globally.
- Majority of
sequencing services conducted on the DNBSEQ NGS platform.
- Offices in Denmark,
the U.S., China, and Japan.
- DirectLabs, LLC.
(U.S.)
- Founded in 1993,
DirectLabs offers direct access laboratory testing across the U.S.
- Aims to prevent and
detect early disease through affordable direct-to-consumer laboratory
testing services.
- Novogene Co.,
Ltd. (China)
- Founded in 2011,
Novogene operates as a genomics solution provider globally.
- Expertise in NGS;
subsidiaries in the U.S., China, Singapore, the U.K., and other regions.
- PerkinElmer, Inc.
(U.S.)
- Established in 1937,
PerkinElmer offers products and services for the life sciences,
diagnostics, and applied markets.
- Rebranded its
genomics services business as Revvity Omics in May 2023.
- Macrogen, Inc.
(South Korea)
- Founded in 1997,
Macrogen offers precision medicine and NGS services globally.
- Subsidiaries and
branches in the U.S., Europe, Singapore, Japan, and Spain.
- QIAGEN N.V.
(Netherlands)
- Founded in 1984,
QIAGEN provides sample and assay technologies for molecular diagnostics
and research.
- Offers a wide range
of NGS services through its custom laboratory and genomic services.
Download
Free Sample Report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5041
Industry
Insights: For a comprehensive analysis of each
company, including recent financial performance, key products, company
strategies, and partnerships and acquisitions, refer to Meticulous Research®'s
latest report on the Next Generation Sequencing Services Market – Global
Opportunity Analysis and Industry Forecast (2023-2030).
For further
information
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment